Colleen Delaney Email

Founder and Chief Scientific Officer, EVP Research and Development . Deverra Therapeutics

Current Roles

Employees:
15
Revenue:
$1.2M
About
Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.
Deverra Therapeutics Address
1600 Fairview Ave E
Seattle, WA
United States
Deverra Therapeutics Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.